Do you consider NSCLC with multistation N2 involvement appropriate for treatment with neoadjuvant chemoimmunotherapy followed by surgery?  


Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at NYU Winthrop Hospital
Great review by Dr. @Seetharamu.
Medical Oncologist at University of Utah
I really appreciate this response - I wasn't able ...
Medical Oncologist at Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Thanks for the question. You are correct- there i...
Medical Oncologist at University of Utah
Thank you
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at MUSC Health of Medical University of South Carolina
This treatment paradigm is certainly exciting...
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice

Answer from: Radiation Oncologist at Community Practice